Indole-3-carbinol affects the expression of 5 different genes (CD47, CENPB, ERGIC1, PPRC1, SLC44A1) that, in turn, affect the survival in patients with uterine corpus endometrial carcinoma (CD47), brain lower-grade glioma (CENPB, ERGIC1) and pancreatic adenocarcinoma (PPRC1, SLC44A1), respectively (Table 1). The gene discussed is SLC44A1; the disease is pancreatic adenocarcinoma.